Alvotech (ALVO) intrinsic value & 10-year financials
Alvotech (ALVO) has a Graham intrinsic value of $3.32 per share. Over the last 7 fiscal years revenue grew 54.5% a year to $586.3M, with an average return on invested capital of -22.1%.
- Graham intrinsic value
- $3.32
- Revenue (FY2025)
- $586.3M
- Revenue growth (7-yr CAGR)
- 54.5%
- ROIC (10-yr avg)
- -22.1%
- Free cash flow (FY2025)
- -$114.7M
ALVO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $586.3M | $27.9M | $0.10 | -$114.7M | 13.3% | 5.4% |
| FY2024 | $489.7M | -$231.9M | -$0.87 | -$290.5M | 14.2% | 22.4% |
| FY2023 | $91.4M | -$551.7M | -$2.43 | -$345.4M | -388.1% | -400.3% |
| FY2022 | $83.0M | -$513.6M | -$2.60 | -$350.3M | -417.3% | -169.1% |
| FY2021 | $36.8M | -$101.5M | -$0.92 | -$248.6M | -640.3% | 384.7% |
| FY2020 | $66.6M | -$170.0M | -$1.82 | -$81.8M | -206.5% | 24.2% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Alvotech revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Alvotech returns on capital have been average, hovering around 8.4% ROIC over the decade.
Alvotech capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Alvotech is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $3.32 per share.